Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Genital Herpes: Insights into Sexually Transmitted Infectious Disease.

Jaishankar D, Shukla D.

Microb Cell. 2016 Jun 27;3(9):438-450. doi: 10.15698/mic2016.09.528. Review.

2.

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.

Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, van Benthem BH.

BMC Infect Dis. 2016 Aug 2;16:364. doi: 10.1186/s12879-016-1707-8.

3.

Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.

Shen JH, Huang KY, Chao-Yu C, Chen CJ, Lin TY, Huang YC.

PLoS One. 2015 Aug 7;10(8):e0134178. doi: 10.1371/journal.pone.0134178. eCollection 2015.

4.
5.

Herpes genitalis - Topical zinc sulfate: An alternative therapeutic and modality.

Mahajan BB, Dhawan M, Singh R.

Indian J Sex Transm Dis. 2013 Jan;34(1):32-4. doi: 10.4103/0253-7184.112867.

6.

Application of fractional factorial designs to study drug combinations.

Jaynes J, Ding X, Xu H, Wong WK, Ho CM.

Stat Med. 2013 Jan 30;32(2):307-18. doi: 10.1002/sim.5526. Epub 2012 Aug 1.

7.

HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.

Abu-Raddad LJ, Schiffer JT, Ashley R, Mumtaz G, Alsallaq RA, Akala FA, Semini I, Riedner G, Wilson D.

Epidemics. 2010 Dec;2(4):173-82. doi: 10.1016/j.epidem.2010.08.003. Epub 2010 Sep 15. Review.

8.

Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.

Al-Sulaiman AM, Vallely PJ, Klapper PE.

Clin Vaccine Immunol. 2009 Jun;16(6):931-4. doi: 10.1128/CVI.00036-09. Epub 2009 Apr 15.

9.

Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan.

Doi Y, Ninomiya T, Hata J, Yonemoto K, Tanizaki Y, Arima H, Liu Y, Rahman M, Iida M, Kiyohara Y.

J Epidemiol. 2009;19(2):56-62. Epub 2009 Mar 6.

10.

Treatment and prevention of herpes labialis.

Opstelten W, Neven AK, Eekhof J.

Can Fam Physician. 2008 Dec;54(12):1683-7. Review.

11.

High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.

Lu Z, Brans R, Akhrameyeva NV, Murakami N, Xu X, Yao F.

J Invest Dermatol. 2009 May;129(5):1174-84. doi: 10.1038/jid.2008.349. Epub 2008 Nov 13.

12.

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection.

Looker KJ, Garnett GP, Schmid GP.

Bull World Health Organ. 2008 Oct;86(10):805-12, A.

13.

Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Johnson AJ, Chu CF, Milligan GN.

J Virol. 2008 Oct;82(19):9678-88. doi: 10.1128/JVI.01159-08. Epub 2008 Jul 30.

14.

Genital herpes.

Geretti AM.

Sex Transm Infect. 2006 Dec;82 Suppl 4:iv31-4. No abstract available.

15.

Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003.

Haddow LJ, Dave B, Mindel A, McPhie KA, Chung C, Marks C, Dwyer DE.

Sex Transm Infect. 2006 Jun;82(3):255-9.

16.

How safe is safer sex? High levels of HSV-1 and HSV-2 in female sex workers in London.

Fox J, Taylor GP, Day S, Parry J, Ward H.

Epidemiol Infect. 2006 Oct;134(5):1114-9. Epub 2006 Mar 29.

17.

The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London.

Ramaswamy M, McDonald C, Sabin C, Tenant-Flowers M, Smith M, Geretti AM.

Sex Transm Infect. 2005 Aug;81(4):306-8.

18.

A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2.

Looker KJ, Garnett GP.

Sex Transm Infect. 2005 Apr;81(2):103-7. Review.

19.

Diagnosis of genital herpes by real time PCR in routine clinical practice.

Ramaswamy M, McDonald C, Smith M, Thomas D, Maxwell S, Tenant-Flowers M, Geretti AM.

Sex Transm Infect. 2004 Oct;80(5):406-10.

20.

The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Fran├žois G, Gatcheva N, Hellenbrand W, Jokinen S, Klavs I, Kojouharova M, Kortbeek T, Kriz B, Prosenc K, Roubalova K, Teocharov P, Thierfelder W, Valle M, Van Damme P, Vranckx R.

Sex Transm Infect. 2004 Jun;80(3):185-91.

Supplemental Content

Support Center